CONSULTING SERVICES AGREEMENTConsulting Services Agreement • December 21st, 2018 • Edge Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledDecember 21st, 2018 Company Industry JurisdictionThis CONSULTING SERVICES AGREEMENT (this “Agreement”), is made as of this 15th day of December, 2014, by and between DeLyle Bloomquist (“Consultant”), and PDS Biotechnology Corporation (“Company”) with its corporate headquarters at 675 Highway One, North Brunswick, New Jersey 08902.
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • December 21st, 2018 • Edge Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledDecember 21st, 2018 Company Industry JurisdictionThis CONSULTING SERVICES AGREEMENT (this “Agreement”), is made as of this 26th day of March, 2015 by and between Greg Conn (“Consultant”), and PDS Biotechnology Corporation (“Company”) with its corporate headquarters at 675 Highway One, North Brunswick, New Jersey 08902.
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2018 • Edge Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 21st, 2018 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is effective as of October 11, 2018 (“Effective Date”) by and between Frank K. Bedu-Addo (“Executive”) and PDS Biotechnology Corporation (the “Company”), a Delaware corporation and supersedes any prior employment-related agreement or agreements between the Employer and Executive. Unless the context otherwise requires, all references to a designated section refers to the designated provision of this Agreement.